GE HealthCare Technologies Inc. (GEHC)
NASDAQ: GEHC · Real-Time Price · USD
62.83
-0.24 (-0.38%)
Jul 20, 2026, 4:00 PM EDT - Market closed
GEHC Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,977 | 4,308 | 4,100 | 3,228 | 3,934 | 4,586 |
Depreciation & Amortization | 595 | 578 | 580 | 610 | 633 | 625 |
Stock-Based Compensation | 143 | 130 | 125 | 114 | 67 | 76 |
Other Adjustments | -407 | -517 | -649 | -420 | -362 | -10 |
Change in Receivables | -156 | -216 | -157 | -173 | -218 | -1,179 |
Changes in Inventories | -159 | -142 | -81 | 111 | -402 | -435 |
Changes in Accounts Payable | 165 | 90 | 60 | -100 | 448 | 242 |
Changes in Accrued Expenses | 44 | 94 | 39 | 153 | -37 | - |
Changes in Unearned Revenue | 184 | 81 | 68 | 26 | 138 | -21 |
Changes in Other Operating Activities | -428 | -264 | -80 | 157 | -103 | 34 |
Operating Cash Flow | 2,027 | 1,987 | 1,955 | 2,101 | 2,134 | 1,607 |
Operating Cash Flow Growth | 13.49% | 1.64% | -6.95% | -1.55% | 32.79% | -38.62% |
Capital Expenditures | -508 | -482 | -401 | -387 | -310 | -248 |
Sale of Property, Plant & Equipment | - | - | - | 1 | 4 | 15 |
Purchases of Investments | -111 | -118 | -40 | -48 | -59 | - |
Payments for Business Acquisitions | -2,406 | -378 | -313 | -147 | - | -1,481 |
Other Investing Activities | -116 | -69 | -160 | 23 | -33 | -47 |
Investing Cash Flow | -3,140 | -1,047 | -914 | -558 | -398 | -1,761 |
Short-Term Debt Issued | -1 | 1 | - | -12 | 7 | -7 |
Net Short-Term Debt Issued (Repaid) | -1 | 1 | - | -12 | 7 | -7 |
Long-Term Debt Issued | 3,886 | 2,734 | 995 | 2,006 | 8,198 | 5 |
Long-Term Debt Repaid | -2,513 | -1,767 | -1,418 | -855 | -3 | -10 |
Net Long-Term Debt Issued (Repaid) | 1,373 | 967 | -423 | 1,151 | 8,195 | -5 |
Issuance of Common Stock | 27 | 37 | 33 | 34 | - | - |
Repurchase of Common Stock | -333 | -242 | -93 | -33 | - | - |
Net Common Stock Issued (Repurchased) | -306 | -205 | -60 | 1 | - | - |
Common Dividends Paid | -64 | -64 | -55 | -41 | - | - |
Other Financing Activities | -77 | -81 | -34 | -1,577 | -9,026 | -251 |
Financing Cash Flow | 924 | 617 | -573 | -478 | -822 | -263 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -66 | 66 | -77 | -14 | -24 | -34 |
Net Cash Flow | -188 | 1,623 | 387 | 1,055 | 890 | -451 |
Free Cash Flow | 1,519 | 1,505 | 1,554 | 1,714 | 1,824 | 1,359 |
Free Cash Flow Growth | 0.93% | -3.15% | -9.34% | -6.03% | 34.22% | -42.92% |
FCF Margin | 7.24% | 7.30% | 7.90% | 8.77% | 9.94% | 7.73% |
Free Cash Flow Per Share | 3.32 | 3.29 | 3.39 | 3.74 | 4.02 | 2.99 |
Levered Free Cash Flow | 3,175 | 3,007 | 1,755 | 3,094 | 10,485 | 2,432 |
Unlevered Free Cash Flow | 1,921 | 2,105 | 2,270 | 2,239 | 2,324 | 2,409 |